GDRX vs NOC · P/E 49, rev $394.4M vs P/E 17, rev $20.76B
Goodrx Holdings Inc (GDRX) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Goodrx Holdings Inc (GDRX) is a health information services company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported GDRX revenue for 2026-06-30 was $394.4M. Net income was $9.7M. GDRX currently screens at market cap $988.9M and trailing P/E 48.7.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
GDRX currently screens at market cap $988.9M and trailing P/E 48.7. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the GDRX and NOC stock pages for the full models.
Not investment advice.